10:22 AM EDT, 06/20/2024 (MT Newswires) -- Bionano Genomics ( BNGO ) said Thursday it has signed a software marketing agreement with Revvity ( RVTY ) to market and commercialize VIA software.

Financial details of the agreement weren't disclosed.

Bionano said its VIA software will be marketed as part of Revvity's ( RVTY ) newborn sequencing research workflow and is expected to improve Revvity's ( RVTY ) newborn sequencing solution by integrating copy number variation assessment into the next generation sequencing report and enhancing workflow interpretation capabilities.

Price: 0.80, Change: +0.02, Percent Change: +3.10